AI assistant
Sending…
TherapeuticsMD, Inc. — Director's Dealing 2020
Jun 4, 2020
35134_dirs_2020-06-04_0cf17bb7-5cc9-42d0-a75d-64b35d1df3c9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: TherapeuticsMD, Inc. (TXMD)
CIK: 0000025743
Period of Report: 2020-06-01
Reporting Person: DArecca James (Chief Financial Officer)
More from TherapeuticsMD, Inc.
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Major Shareholding Notification
2026
Apr 7
Annual Report
2026
Apr 1
Regulatory Filings
2026
Apr 1
Regulatory Filings
2026
Mar 30
Annual Report
2026
Mar 30
Regulatory Filings
2026
Jan 20
Director's Dealing
2025
Dec 29
Regulatory Filings
2025
Dec 16